Wednesday’s analyst upgrades and downgrades

National Bank Financial analyst Cameron Doerksen raised Bombardier (BBD.B-T) target to C$349 from C$296 ahead of Q2 results July 30, citing strong biz-jet and Defense momentum and valuation concerns. He kept a “sector outperform” rating, noting BBD trades at 16.3x EV/EBITDA vs peers 13.3x. TD Cowen initiated Tecsys (TCS-T) at “buy” with C$39 target, citing SaaS growth and takeout upside.

Original reporting
Published Jul 8, 2026, 11:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 11:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wednesday’s analyst upgrades and downgrades — source image
Decision brief

The 30-second read

$BBDBullishMed
01

Why it matters

The actionable elements are the specific target changes and the valuation/margin/takeout theses that can shift near-term positioning and expectations ahead of upcoming earnings for Bombardier.

02

Market read

Traders may adjust exposure based on valuation framing and the timing of Bombardier’s earnings, while Tecsys may see sentiment lift from new coverage and upside math.

03

What to watch

For Bombardier, the note attributes strength partly to CAD weakness and scarcity of defense-exposed Canadian stocks, which can reverse. For Tecsys, the discount is tied to legacy/noncore dilution, so execution on segment simplification and cloud/margin delivery is key.

Relevance 7/10Novelty 6/10Timing: ahead of Bombardier’s July 30 Q2 earnings; Tecsys initiation coverage is current for positioning

Background

This is a roundup of analyst actions, including Bombardier’s target increase ahead of its Q2 release and TD Cowen’s initiation of Tecsys with a buy rating.

Company-level read

Ticker impact

$BBDBullishMedium confidence
Context

Bombardier is the subject of an analyst note ahead of its July 30 Q2 results, citing valuation premium and raising its target to $349.

Expected impact

Moderate positive bias for sentiment, but limited near-term upside per the analyst’s own “better entry on pullback” framing.

Evidence & confidence

The article provides a specific target increase and multiple change, but it is still an analyst action rather than a new company disclosure.

Market effects

Highlights valuation sensitivity in business aviation and Defense exposure, and suggests healthcare supply chain SaaS may be mispriced versus peers.

Canada-focused catalysts: Bombardier’s upcoming earnings and Montreal-based Tecsys coverage.

Defense and business-jet demand read-through (utilization, departures) can influence broader aerospace sentiment.

Counterpoint

Analyst targets may lag reality if valuation compression resumes or Defense contract timing slips; Tecsys upside depends on margin convergence and takeout optionality that may not materialize.

Key entities

  • Bombardier Inc.

    Analyst raised target to $349, citing elevated valuation versus peers but bullish end markets and Defense momentum.

  • Tecsys Inc.

    TD Cowen initiated coverage with a buy rating and $39 target, arguing SaaS mispricing and potential takeout premium.

Related articles

$BBDMed

Bradesco Launches Corporate Crypto Custody With Foxbit as First Client

Bradesco launched corporate crypto custody in Brazil, naming Foxbit as its first client, according to Bradesco’s Q2 2026 earnings release on Aug. 6, 2026. The bank said custody and brokerage revenue rose 26.4% year over year to R$600 million, while assets under custody totaled R$2.8 trillion. The service targets institutional firms amid new central bank anti-fraud rules.

$BBDMed

Banco Bradesco Q2 Earnings Call Highlights

Banco Bradesco reported Q2 call highlights: vehicle financing up 26.8% YoY and payroll-deductible lending up 9.3%. Delinquency over 90 days was 2.5% vs 3.3% market. Cost of risk held at 3.5%. CFO said market NII could approach BRL 2 billion and NIM near 9%. Planned BRL 10 billion capital raise pending approval.

$BBDMedAI 8/10

Bradesco Q2 Profit Hits US$1.4 Billion as Bad Loans Rise

Banco Bradesco reported Q2 recurring net income of R$7.05 billion (US$1.38 billion), up 16.2% year over year, with ROE near 16.2%. Total revenues rose to R$37.6 billion. Credit outstanding grew to R$1.14 trillion, while loans over 90 days overdue increased to 4.3% and provisions rose 22.6% to R$10.0 billion. Bradesco is also raising up to R$10 billion via private share subscription.

$ITUBMed

Itaú Colombia Sells Retail Unit to Banco De Bogotá

Banco Itaú Colombia, part of Itaú group, completed the sale of its retail or “persona natural” banking unit in Colombia to Banco de Bogotá (Grupo Aval). The transfer closed July 31, 2026, with migration Aug 1 and access from Aug 2. About 267,000 customers moved. The portfolio transferred was nearly COP 6.45T in loans and COP 4.80T in deposits for about COP 1.64T (US$520M).

$SANMed

A Judge Says Two of Brazil’s Biggest Banks Helped Hide Americanas Debt

Brazilian federal judge Giovana Calmon authorized late-June searches of Itaú, Santander and Bradesco executives in the Americanas fraud case, citing indications the banks helped hide supplier-finance (risco sacado) debts. Police allege supplier-finance was omitted from circularisation letters to auditors. Itaú denies coordination. Americanas’ asset freeze totals up to 54 billion reais.